Literature DB >> 3497251

Recreational use of psychoactive drugs by patients with cystic fibrosis.

R C Stern, P J Byard, J F Tomashefski, C F Doershuk.   

Abstract

We assessed unprescribed psychoactive drug use in 173 adults with cystic fibrosis. Twenty (11%) regularly smoked tobacco. Cigarette smoking ranged from 1 to 30 years (2 to 60 pack-years). Alcohol was used by 60%, and marijuana by 20% of the patients. Pulmonary symptoms were often increased the day after alcohol ingestion. Alcohol occasionally caused nausea, vomiting, and headache if the patient was taking some cephalosporin derivatives (such as cefsulodine) or chloramphenicol. Marijuana often aggravated chronic pulmonary symptoms, although some patients reported transient relief during use. Comparison with a retrospectively selected control group did not show faster short-term pulmonary deterioration in the tobacco smokers. Physicians who deal with cystic fibrosis and other chronic illnesses should be cognizant of interactions of unprescribed and prescribed drugs. Recreational use of unprescribed psychoactive drugs should be considered if unexpected symptoms occur in older patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497251     DOI: 10.1016/s0022-3476(87)80090-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Smoking prevention and cessation programme in cystic fibrosis: integrating an environmental health approach.

Authors:  Juan Antonio Ortega-García; María Trinidad López-Fernández; Rayden Llano; María Dolores Pastor-Vivero; Pedro Mondéjar-López; Miguel Felipe Sánchez-Sauco; Manuel Sánchez-Solís
Journal:  J Cyst Fibros       Date:  2011-10-13       Impact factor: 5.482

Review 2.  Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.

Authors:  Jeanette M Tetrault; Kristina Crothers; Brent A Moore; Reena Mehra; John Concato; David A Fiellin
Journal:  Arch Intern Med       Date:  2007-02-12

3.  "Bong lung" in cystic fibrosis: a case report.

Authors:  Zoe Gao; Richard Wood-Baker; Robin Harle; Kon Muller; Jenny Hauser; David W Reid
Journal:  J Med Case Rep       Date:  2010-11-19

4.  Long term follow-up of a tobacco prevention and cessation program in cystic fibrosis patients.

Authors:  Juan Antonio Ortega-García; Joseph E Perales; Alberto Cárceles-Álvarez; Miguel Felipe Sánchez-Sauco; Seiichi Villalona; Pedro Mondejar-López; María Dolores Pastor-Vivero; Pilar Mira Escolano; Diana Carolina James-Vega; Manuel Sánchez-Solís
Journal:  Adicciones       Date:  2016-03-02       Impact factor: 2.979

Review 5.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

6.  Use of medical marijuana in cystic fibrosis patients.

Authors:  Michael J Stephen; Jared Chowdhury; Luis Arzeno Tejada; Robert Zanni; Denis Hadjiliadis
Journal:  BMC Complement Med Ther       Date:  2020-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.